Guidant Catches Boston Scientific’s “Hail Mary” Offer; J&J Weighs Options
This article was originally published in The Gray Sheet
Executive Summary
Guidant's board of directors determined Jan. 17 that Boston Scientific's latest acquisition offer of $80 per share, or $27.2 bil., is superior to its previous agreement with Johnson & Johnson for $71 per share
You may also be interested in...
Guidant Accepts Yet Another J&J Bid As Takeover War Escalates
Guidant accepted an increased takeover bid by Johnson & Johnson late Jan. 13, leaving Boston Scientific to once again weigh whether to continue its bidding war with J&J
Abbott Vascular Ripens With Anticipated 2005 Launches Of Stent, Sealant
Rapid hospital discharges associated with Abbott's StarClose will favor the device over manual femoral access closure methods upon launch in the second half of 2005, the firm claims
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.